» Authors » G Mieli-Vergani

G Mieli-Vergani

Explore the profile of G Mieli-Vergani including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 222
Citations 2643
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
de Boer Y, Liberal R, Vergani D, Mieli-Vergani G
United European Gastroenterol J . 2018 Sep; 6(7):1032-1038. PMID: 30228891
Background And Aims: Juvenile autoimmune liver disease (JAILD) includes paediatric forms of autoimmune hepatitis (AIH) and autoimmune sclerosing cholangitis (ASC). Since evidence is scarce, there are currently no evidence-based management...
2.
Grant C, Holder B, Liberal R, Heneghan M, Ma Y, Mieli-Vergani G, et al.
Clin Exp Immunol . 2017 Mar; 189(1):71-82. PMID: 28257599
Autoimmune hepatitis (AIH) is characterized by overwhelming effector immune responses associated with defective regulatory T cells (T ). Several lines of evidence indicate CD4 as the main effectors involved in...
3.
Liberal R, Mieli-Vergani G, Vergani D
Rev Clin Esp (Barc) . 2016 May; 216(7):372-383. PMID: 27161382
Autoimmune hepatitis (AIH) is a progressive inflammatory hepatopathy and an important cause of end-stage liver disease. Its aetiology remains unknown, though both genetic and environmental factors are involved in its...
4.
Carey I, Bruce M, Horner M, Zen Y, DAntiga L, Bansal S, et al.
J Viral Hepat . 2014 Oct; 22(4):441-52. PMID: 25278170
We aimed to investigate the ability of HBsAg plasma level kinetics to predict therapy response by studying 23 children with infancy-acquired chronic hepatitis B (CHB) during combination sequential therapy with...
5.
Abdel-Hady M, Bansal S, Davison S, Brown M, Tizzard S, Mulla S, et al.
Arch Dis Child . 2014 Feb; 99(6):505-10. PMID: 24492797
Aim: To review the efficacy and tolerability of pegylated interferon-α and ribavirin for treatment of chronic hepatitis C (CHC) in children in the UK. Methods: Retrospective review of children treated...
6.
Fitzpatrick E, Jardine R, Farrant P, Karani J, Davenport M, Mieli-Vergani G, et al.
J Pediatr Gastroenterol Nutr . 2010 Jun; 51(1):55-60. PMID: 20543724
Objectives: : The significance of extrahepatic bile duct dilatation on ultrasound examination in jaundiced infants is often uncertain. We wished to clarify the diagnostic and prognostic significance of the present...
7.
Galbiati G, Muraca M, Mitry R, Hughes R, Lehec S, Puppi J, et al.
J Pediatr Gastroenterol Nutr . 2010 Apr; 50(6):691-3. PMID: 20400908
The availability of cryopreserved hepatocytes is required for a more widespread use of hepatocyte transplantation, but human hepatocytes are easily damaged during freezing-thawing. Here, preincubation with unconjugated bilirubin, a physiological...
8.
Antonelli A, Ferri C, Galeazzi M, Giannitti C, Manno D, Mieli-Vergani G, et al.
Clin Exp Rheumatol . 2008 Jul; 26(1 Suppl 48):S39-47. PMID: 18570753
Chronic hepatitis C virus (HCV) infection is a worldwide public health problem with a global prevalence of 2-3%. It is believed that about 170 million people are currently infected (about...
9.
Heaton N, Faraj W, Melendez H, Jassem W, Muiesan P, Mieli-Vergani G, et al.
Br J Surg . 2008 May; 95(7):919-24. PMID: 18496888
Background: Living related liver transplantation (LRLT) has become established for treating children with end-stage liver disease. The aim of this study was to review a single-centre experience of left lateral...
10.
Sutcliffe R, Mieli-Vergani G, Dhawan A, Corbally M, Karani J, Heaton N
J Pediatr Surg . 2008 Mar; 43(3):571-3. PMID: 18358306
Congenital hepatoportal arteriovenous fistula is a rare cause of portal hypertension in young children. Unlike the acquired form, which is usually isolated and can be cured by hepatic artery (HA)...